<?xml version='1.0' encoding='UTF-8'?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="2005-12-06" modified="2019-07-03" version="107">
<accession>P0AE72</accession>
<accession>P18534</accession>
<accession>Q2MA49</accession>
<name>MAZE_ECOLI</name>
<protein>
<recommendedName>
<fullName>Antitoxin MazE</fullName>
</recommendedName>
</protein>
<gene>
<name type="primary">mazE</name>
<name type="synonym">chpAI</name>
<name type="synonym">chpR</name>
<name type="ordered locus">b2783</name>
<name type="ordered locus">JW2754</name>
</gene>
<organism>
<name type="scientific">Escherichia coli (strain K12)</name>
<dbReference type="NCBI Taxonomy" id="83333"/>
<lineage>
<taxon>Bacteria</taxon>
<taxon>Proteobacteria</taxon>
<taxon>Gammaproteobacteria</taxon>
<taxon>Enterobacterales</taxon>
<taxon>Enterobacteriaceae</taxon>
<taxon>Escherichia</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1988" name="J. Biol. Chem." volume="263" first="15699" last="15704">
<title>The nucleotide sequence and characterization of the relA gene of Escherichia coli.</title>
<authorList>
<person name="Metzger S."/>
<person name="Dror I.B."/>
<person name="Aizenman E."/>
<person name="Schreiber G."/>
<person name="Toone M."/>
<person name="Friesen J.D."/>
<person name="Cashel M."/>
<person name="Glaser G."/>
</authorList>
<dbReference type="PubMed" id="2844820"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
<scope>OPERON STRUCTURE</scope>
<source>
<strain>K12</strain>
</source>
</reference>
<reference key="2">
<citation type="journal article" date="1993" name="J. Bacteriol." volume="175" first="6850" last="6856">
<title>chpA and chpB, Escherichia coli chromosomal homologs of the pem locus responsible for stable maintenance of plasmid R100.</title>
<authorList>
<person name="Masuda Y."/>
<person name="Miyakawa K."/>
<person name="Nishimura Y."/>
<person name="Ohtsubo E."/>
</authorList>
<dbReference type="PubMed" id="8226627"/>
<dbReference type="DOI" id="10.1128/jb.175.21.6850-6856.1993"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
<source>
<strain>K12 / MC1000 / ATCC 39531</strain>
</source>
</reference>
<reference key="3">
<citation type="journal article" date="1997" name="Science" volume="277" first="1453" last="1462">
<title>The complete genome sequence of Escherichia coli K-12.</title>
<authorList>
<person name="Blattner F.R."/>
<person name="Plunkett G. III"/>
<person name="Bloch C.A."/>
<person name="Perna N.T."/>
<person name="Burland V."/>
<person name="Riley M."/>
<person name="Collado-Vides J."/>
<person name="Glasner J.D."/>
<person name="Rode C.K."/>
<person name="Mayhew G.F."/>
<person name="Gregor J."/>
<person name="Davis N.W."/>
<person name="Kirkpatrick H.A."/>
<person name="Goeden M.A."/>
<person name="Rose D.J."/>
<person name="Mau B."/>
<person name="Shao Y."/>
</authorList>
<dbReference type="PubMed" id="9278503"/>
<dbReference type="DOI" id="10.1126/science.277.5331.1453"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
<source>
<strain>K12 / MG1655 / ATCC 47076</strain>
</source>
</reference>
<reference key="4">
<citation type="journal article" date="2006" name="Mol. Syst. Biol." volume="2" first="E1" last="E5">
<title>Highly accurate genome sequences of Escherichia coli K-12 strains MG1655 and W3110.</title>
<authorList>
<person name="Hayashi K."/>
<person name="Morooka N."/>
<person name="Yamamoto Y."/>
<person name="Fujita K."/>
<person name="Isono K."/>
<person name="Choi S."/>
<person name="Ohtsubo E."/>
<person name="Baba T."/>
<person name="Wanner B.L."/>
<person name="Mori H."/>
<person name="Horiuchi T."/>
</authorList>
<dbReference type="PubMed" id="16738553"/>
<dbReference type="DOI" id="10.1038/msb4100049"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
<source>
<strain>K12 / W3110 / ATCC 27325 / DSM 5911</strain>
</source>
</reference>
<reference key="5">
<citation type="journal article" date="1996" name="Proc. Natl. Acad. Sci. U.S.A." volume="93" first="6059" last="6063">
<title>An Escherichia coli chromosomal 'addiction module' regulated by guanosine 3',5'-bispyrophosphate: a model for programmed bacterial cell death.</title>
<authorList>
<person name="Aizenman E."/>
<person name="Engelberg-Kulka H."/>
<person name="Glaser G."/>
</authorList>
<dbReference type="PubMed" id="8650219"/>
<dbReference type="DOI" id="10.1073/pnas.93.12.6059"/>
</citation>
<scope>FUNCTION</scope>
<scope>CLEAVAGE BY THE CLPPA PROTEASE</scope>
<scope>INTERACTION WITH MAZF</scope>
<scope>INDUCTION</scope>
<scope>OPERON STRUCTURE</scope>
<source>
<strain>K12 / MC4100 / ATCC 35695 / DSM 6574</strain>
</source>
</reference>
<reference key="6">
<citation type="journal article" date="2001" name="J. Biol. Chem." volume="276" first="5975" last="5984">
<title>The regulation of the Escherichia coli mazEF promoter involves an unusual alternating palindrome.</title>
<authorList>
<person name="Marianovsky I."/>
<person name="Aizenman E."/>
<person name="Engelberg-Kulka H."/>
<person name="Glaser G."/>
</authorList>
<dbReference type="PubMed" id="11071896"/>
<dbReference type="DOI" id="10.1074/jbc.M008832200"/>
</citation>
<scope>TRANSCRIPTION REGULATION</scope>
<scope>DNA-BINDING</scope>
<scope>SUBUNIT</scope>
<source>
<strain>K12 / MC4100 / ATCC 35695 / DSM 6574</strain>
</source>
</reference>
<reference key="7">
<citation type="journal article" date="2002" name="Mol. Microbiol." volume="45" first="501" last="510">
<title>Rapid induction and reversal of a bacteriostatic condition by controlled expression of toxins and antitoxins.</title>
<authorList>
<person name="Pedersen K."/>
<person name="Christensen S.K."/>
<person name="Gerdes K."/>
</authorList>
<dbReference type="PubMed" id="12123459"/>
<dbReference type="DOI" id="10.1046/j.1365-2958.2002.03027.x"/>
</citation>
<scope>FUNCTION AS AN ANTITOXIN</scope>
<source>
<strain>K12</strain>
</source>
</reference>
<reference key="8">
<citation type="journal article" date="2003" name="J. Biol. Chem." volume="278" first="14101" last="14111">
<title>Recognition of the intrinsically flexible addiction antidote MazE by a dromedary single domain antibody fragment. Structure, thermodynamics of binding, stability, and influence on interactions with DNA.</title>
<authorList>
<person name="Lah J."/>
<person name="Marianovsky I."/>
<person name="Glaser G."/>
<person name="Engelberg-Kulka H."/>
<person name="Kinne J."/>
<person name="Wyns L."/>
<person name="Loris R."/>
</authorList>
<dbReference type="PubMed" id="12533537"/>
<dbReference type="DOI" id="10.1074/jbc.M209855200"/>
</citation>
<scope>FUNCTION</scope>
<scope>SUBUNIT</scope>
<scope>DNA-BINDING</scope>
</reference>
<reference key="9">
<citation type="journal article" date="2003" name="J. Mol. Biol." volume="332" first="809" last="819">
<title>Toxin-antitoxin loci as stress-response-elements: ChpAK/MazF and ChpBK cleave translated RNAs and are counteracted by tmRNA.</title>
<authorList>
<person name="Christensen S.K."/>
<person name="Pedersen K."/>
<person name="Hansen F.G."/>
<person name="Gerdes K."/>
</authorList>
<dbReference type="PubMed" id="12972253"/>
<dbReference type="DOI" id="10.1016/S0022-2836(03)00922-7"/>
</citation>
<scope>INDUCTION</scope>
<scope>POSSIBLE CLEAVAGE BY THE LON PROTEASE</scope>
<scope>DISRUPTION PHENOTYPE</scope>
<source>
<strain>K12 / MG1655 / ATCC 47076</strain>
</source>
</reference>
<reference key="10">
<citation type="journal article" date="2004" name="J. Bacteriol." volume="186" first="8295" last="8300">
<title>MazF-mediated cell death in Escherichia coli: a point of no return.</title>
<authorList>
<person name="Amitai S."/>
<person name="Yassin Y."/>
<person name="Engelberg-Kulka H."/>
</authorList>
<dbReference type="PubMed" id="15576778"/>
<dbReference type="DOI" id="10.1128/JB.186.24.8295-8300.2004"/>
</citation>
<scope>ROLE IN PROGRAMMED CELL DEATH</scope>
<source>
<strain>K12 / MC4100 / ATCC 35695 / DSM 6574</strain>
</source>
</reference>
<reference key="11">
<citation type="journal article" date="2004" name="Mol. Genet. Genomics" volume="272" first="227" last="234">
<title>Escherichia coli mazEF-mediated cell death as a defense mechanism that inhibits the spread of phage P1.</title>
<authorList>
<person name="Hazan R."/>
<person name="Engelberg-Kulka H."/>
</authorList>
<dbReference type="PubMed" id="15316771"/>
<dbReference type="DOI" id="10.1007/s00438-004-1048-y"/>
</citation>
<scope>FUNCTION IN PHAGE IMMUNITY</scope>
<scope>DISRUPTION PHENOTYPE</scope>
<source>
<strain>K12 / JM109 / ATCC 53323</strain>
<strain>K12 / K38 / S26</strain>
<strain>K12 / MC4100 / ATCC 35695 / DSM 6574</strain>
</source>
</reference>
<reference key="12">
<citation type="journal article" date="2006" name="Mol. Microbiol." volume="59" first="590" last="601">
<title>MazG -- a regulator of programmed cell death in Escherichia coli.</title>
<authorList>
<person name="Gross M."/>
<person name="Marianovsky I."/>
<person name="Glaser G."/>
</authorList>
<dbReference type="PubMed" id="16390452"/>
<dbReference type="DOI" id="10.1111/j.1365-2958.2005.04956.x"/>
</citation>
<scope>INDUCTION</scope>
<scope>OPERON STRUCTURE</scope>
<source>
<strain>K12 / MC4100 / ATCC 35695 / DSM 6574</strain>
<strain>K12 / W3110 / ATCC 27325 / DSM 5911</strain>
</source>
</reference>
<reference key="13">
<citation type="journal article" date="2009" name="Mol. Cell" volume="36" first="845" last="860">
<title>Hydroxyurea induces hydroxyl radical-mediated cell death in Escherichia coli.</title>
<authorList>
<person name="Davies B.W."/>
<person name="Kohanski M.A."/>
<person name="Simmons L.A."/>
<person name="Winkler J.A."/>
<person name="Collins J.J."/>
<person name="Walker G.C."/>
</authorList>
<dbReference type="PubMed" id="20005847"/>
<dbReference type="DOI" id="10.1016/j.molcel.2009.11.024"/>
</citation>
<scope>DISRUPTION PHENOTYPE</scope>
<source>
<strain>K12 / MC4100 / ATCC 35695 / DSM 6574</strain>
</source>
</reference>
<reference key="14">
<citation type="journal article" date="2009" name="PLoS ONE" volume="4" first="E6785" last="E6785">
<title>A differential effect of E. coli toxin-antitoxin systems on cell death in liquid media and biofilm formation.</title>
<authorList>
<person name="Kolodkin-Gal I."/>
<person name="Verdiger R."/>
<person name="Shlosberg-Fedida A."/>
<person name="Engelberg-Kulka H."/>
</authorList>
<dbReference type="PubMed" id="19707553"/>
<dbReference type="DOI" id="10.1371/journal.pone.0006785"/>
</citation>
<scope>FUNCTION IN CELL DEATH</scope>
<scope>FUNCTION IN BIOFILM FORMATION</scope>
<scope>DISRUPTION PHENOTYPE</scope>
<source>
<strain>K12 / MC4100 / ATCC 35695 / DSM 6574</strain>
</source>
</reference>
<reference key="15">
<citation type="journal article" date="2011" name="Mol. Cell" volume="41" first="625" last="635">
<title>The Escherichia coli extracellular death factor EDF induces the endoribonucleolytic activities of the toxins MazF and ChpBK.</title>
<authorList>
<person name="Belitsky M."/>
<person name="Avshalom H."/>
<person name="Erental A."/>
<person name="Yelin I."/>
<person name="Kumar S."/>
<person name="London N."/>
<person name="Sperber M."/>
<person name="Schueler-Furman O."/>
<person name="Engelberg-Kulka H."/>
</authorList>
<dbReference type="PubMed" id="21419338"/>
<dbReference type="DOI" id="10.1016/j.molcel.2011.02.023"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="16">
<citation type="journal article" date="2013" name="BMC Microbiol." volume="13" first="45" last="45">
<title>Transcriptional cross-activation between toxin-antitoxin systems of Escherichia coli.</title>
<authorList>
<person name="Kasari V."/>
<person name="Mets T."/>
<person name="Tenson T."/>
<person name="Kaldalu N."/>
</authorList>
<dbReference type="PubMed" id="23432955"/>
<dbReference type="DOI" id="10.1186/1471-2180-13-45"/>
</citation>
<scope>INDUCTION BY OTHER TA SYSTEMS</scope>
<source>
<strain>K12 / BW25113</strain>
</source>
</reference>
<reference key="17">
<citation type="journal article" date="2014" name="J. Biol. Chem." volume="289" first="4191" last="4205">
<title>MazF-induced growth inhibition and persister generation in Escherichia coli.</title>
<authorList>
<person name="Tripathi A."/>
<person name="Dewan P.C."/>
<person name="Siddique S.A."/>
<person name="Varadarajan R."/>
</authorList>
<dbReference type="PubMed" id="24375411"/>
<dbReference type="DOI" id="10.1074/jbc.M113.510511"/>
</citation>
<scope>CLEAVAGE BY LON AND CLPP</scope>
<source>
<strain>K12 / BW25113</strain>
<strain>K12 / MC4100 / ATCC 35695 / DSM 6574</strain>
</source>
</reference>
<reference key="18">
<citation type="journal article" date="2009" name="Prog. Mol. Biol. Transl. Sci." volume="85" first="467" last="500">
<title>mRNA interferases, sequence-specific endoribonucleases from the toxin-antitoxin systems.</title>
<authorList>
<person name="Yamaguchi Y."/>
<person name="Inouye M."/>
</authorList>
<dbReference type="PubMed" id="19215780"/>
<dbReference type="DOI" id="10.1016/S0079-6603(08)00812-X"/>
</citation>
<scope>REVIEW</scope>
</reference>
<reference key="19">
<citation type="journal article" date="2003" name="J. Biol. Chem." volume="278" first="28252" last="28257">
<title>Crystal structure of the intrinsically flexible addiction antidote MazE.</title>
<authorList>
<person name="Loris R."/>
<person name="Marianovsky I."/>
<person name="Lah J."/>
<person name="Laeremans T."/>
<person name="Engelberg-Kulka H."/>
<person name="Glaser G."/>
<person name="Muyldermans S."/>
<person name="Wyns L."/>
</authorList>
<dbReference type="PubMed" id="12743116"/>
<dbReference type="DOI" id="10.1074/jbc.M302336200"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (1.65 ANGSTROMS) IN COMPLEX WITH AN ANTIBODY FRAGMENT</scope>
<scope>DNA-BINDING</scope>
<scope>MUTAGENESIS OF ARG-8 AND ARG-16</scope>
</reference>
<reference key="20">
<citation type="journal article" date="2003" name="Mol. Cell" volume="11" first="875" last="884">
<title>Crystal structure of the MazE/MazF complex: molecular bases of antidote-toxin recognition.</title>
<authorList>
<person name="Kamada K."/>
<person name="Hanaoka F."/>
<person name="Burley S.K."/>
</authorList>
<dbReference type="PubMed" id="12718874"/>
<dbReference type="DOI" id="10.1016/S1097-2765(03)00097-2"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (1.7 ANGSTROMS)</scope>
<scope>SUBUNIT</scope>
</reference>
<reference key="21">
<citation type="journal article" date="2015" name="Nucleic Acids Res." volume="43" first="1241" last="1256">
<title>Escherichia coli antitoxin MazE as transcription factor: insights into MazE-DNA binding.</title>
<authorList>
<person name="Zorzini V."/>
<person name="Buts L."/>
<person name="Schrank E."/>
<person name="Sterckx Y.G."/>
<person name="Respondek M."/>
<person name="Engelberg-Kulka H."/>
<person name="Loris R."/>
<person name="Zangger K."/>
<person name="van Nuland N.A."/>
</authorList>
<dbReference type="PubMed" id="25564525"/>
<dbReference type="DOI" id="10.1093/nar/gku1352"/>
</citation>
<scope>STRUCTURE BY NMR OF 2-50 IN COMPLEX WITH DNA</scope>
<scope>FUNCTION</scope>
<scope>SUBUNIT</scope>
<scope>DNA-BINDING</scope>
</reference>
<comment type="function">
<text evidence="4 5 6 13 15 18 19">Antitoxin component of a type II toxin-antitoxin (TA) system. Labile antitoxin that binds to the MazF endoribonuclease toxin and neutralizes its endoribonuclease activity. Is considered to be an 'addiction' molecule as the cell dies in its absence. Toxicity results when the levels of MazE decrease in the cell, leading to mRNA degradation. This effect can be rescued by expression of MazE, but after 6 hours in rich medium the overexpression of MazF leads to programmed cell death. Cell growth and viability are not affected when MazF and MazE are coexpressed. Both MazE and MazE-MazF bind to the promoter region of the mazE-mazF operon to inhibit their own transcription (PubMed:8650219). There are 3 operators to which MazE binds (PubMed:12533537). MazE has higher affinity for promoter DNA in the presence of MazF (PubMed:25564525).</text>
</comment>
<comment type="function">
<text evidence="11 13">Cell death governed by the MazE-MazF and DinJ-YafQ TA systems seems to play a role in biofilm formation, while MazE-MazF is also implicated in cell death in liquid media.</text>
</comment>
<comment type="function">
<text evidence="10">Might also serve to protect cells against bacteriophage; in the presence of MazE-MazF fewer P1 phage are produced than in a disrupted strain. For strain K38 most wild-type cells are killed but not by phage lysis; it was suggested that MazE-MazF causes P1 phage exclusion from the bacterial population. This phenomenon is strain dependent.</text>
</comment>
<comment type="subunit">
<text evidence="4 6 7 8 18 19">Probably forms a homodimer in the absence of MazF; binds DNA as a homodimer (PubMed:25564525, PubMed:12533537). Forms a heterohexamer composed of alternating toxin and antitoxin homodimers MazF(2)-MazE(2)-MazF(2).</text>
</comment>
<comment type="induction">
<text evidence="4 9 12 16 19">Expressed in exponentially growing cells. Induction has been reported to occur after amino acid starvation in a ppGpp-independent fashion and to be Lon protease-dependent (PubMed:12972253), but also to not occur after amino acid starvation and to be regulated by ppGpp (PubMed:8650219). MazE alone and in combination with MazF, represses transcription of the mazE-mazF operon. Fis activates transcription. Part of the relA-mazE-mazF-mazG operon, there is also a second mazE-mazF specific promoter which is negatively autoregulated. This operon induced by ectopic expression of toxin RelE; induction of this operon by amino acid starvation requires the relBEF operon (PubMed:23432955).</text>
</comment>
<comment type="PTM">
<text evidence="9 17 19">Degraded by the ClpPA and Lon proteases.</text>
</comment>
<comment type="disruption phenotype">
<text evidence="9 10 13 14">Decreased sensitivity to dramatic intracellular increases of ppGpp. Double mazE-mazF disruptions survive high temperature, various DNA-damaging agents and H(2)O(2) exposure better than wild-type cells. They produce more P1 phage than wild-type cells, while introduction of lysogens into a growing non-lysogenic disruption culture is lethal (PubMed:15316771). Double mazE-mazF disruptions show reduced biofilm formation, and survive antibiotic treatment in log phase better than wild-type cells. Cells missing mazE-mazF survive hydroxyurea treatment better than wild-type; further disruption of relE-relB and tonB yields even better survival (PubMed:20005847).</text>
</comment>
<comment type="similarity">
<text evidence="20">Belongs to the PemI family.</text>
</comment>
<dbReference type="EMBL" id="D16450">
<property type="protein sequence ID" value="BAA41177.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="J04039">
<property type="protein sequence ID" value="AAA03238.1"/>
<property type="molecule type" value="Unassigned_DNA"/>
</dbReference>
<dbReference type="EMBL" id="U29580">
<property type="protein sequence ID" value="AAA69293.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="U00096">
<property type="protein sequence ID" value="AAC75825.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AP009048">
<property type="protein sequence ID" value="BAE76857.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="PIR" id="B31996">
<property type="entry name" value="BVECZE"/>
</dbReference>
<dbReference type="RefSeq" id="NP_417263.1">
<property type="nucleotide sequence ID" value="NC_000913.3"/>
</dbReference>
<dbReference type="RefSeq" id="WP_000581937.1">
<property type="nucleotide sequence ID" value="NZ_LN832404.1"/>
</dbReference>
<dbReference type="PDB" id="1MVF">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.65"/>
<property type="chains" value="D/E=1-82"/>
</dbReference>
<dbReference type="PDB" id="1UB4">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.70"/>
<property type="chains" value="C=1-82"/>
</dbReference>
<dbReference type="PDB" id="2MRN">
<property type="method" value="NMR"/>
<property type="chains" value="A/B=2-50"/>
</dbReference>
<dbReference type="PDB" id="2MRU">
<property type="method" value="NMR"/>
<property type="chains" value="A/B=2-50"/>
</dbReference>
<dbReference type="PDB" id="5CQX">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.63"/>
<property type="chains" value="C=68-82"/>
</dbReference>
<dbReference type="PDB" id="5CQY">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.48"/>
<property type="chains" value="C=68-82"/>
</dbReference>
<dbReference type="PDBsum" id="1MVF"/>
<dbReference type="PDBsum" id="1UB4"/>
<dbReference type="PDBsum" id="2MRN"/>
<dbReference type="PDBsum" id="2MRU"/>
<dbReference type="PDBsum" id="5CQX"/>
<dbReference type="PDBsum" id="5CQY"/>
<dbReference type="SMR" id="P0AE72"/>
<dbReference type="ComplexPortal" id="CPX-1086">
<property type="entry name" value="mazEF toxin-antitoxin complex"/>
</dbReference>
<dbReference type="IntAct" id="P0AE72">
<property type="interactions" value="10"/>
</dbReference>
<dbReference type="STRING" id="511145.b2783"/>
<dbReference type="PaxDb" id="P0AE72"/>
<dbReference type="PRIDE" id="P0AE72"/>
<dbReference type="ABCD" id="P0AE72"/>
<dbReference type="EnsemblBacteria" id="AAC75825">
<property type="protein sequence ID" value="AAC75825"/>
<property type="gene ID" value="b2783"/>
</dbReference>
<dbReference type="EnsemblBacteria" id="BAE76857">
<property type="protein sequence ID" value="BAE76857"/>
<property type="gene ID" value="BAE76857"/>
</dbReference>
<dbReference type="GeneID" id="947245"/>
<dbReference type="KEGG" id="ecj:JW2754"/>
<dbReference type="KEGG" id="eco:b2783"/>
<dbReference type="PATRIC" id="fig|1411691.4.peg.3952"/>
<dbReference type="EchoBASE" id="EB0566"/>
<dbReference type="EcoGene" id="EG10571">
<property type="gene designation" value="mazE"/>
</dbReference>
<dbReference type="eggNOG" id="ENOG4106A2Z">
<property type="taxonomic scope" value="Bacteria"/>
</dbReference>
<dbReference type="eggNOG" id="COG2336">
<property type="taxonomic scope" value="LUCA"/>
</dbReference>
<dbReference type="HOGENOM" id="HOG000289070"/>
<dbReference type="InParanoid" id="P0AE72"/>
<dbReference type="KO" id="K07172"/>
<dbReference type="PhylomeDB" id="P0AE72"/>
<dbReference type="BioCyc" id="EcoCyc:EG10571-MONOMER"/>
<dbReference type="BioCyc" id="ECOL316407:JW2754-MONOMER"/>
<dbReference type="BioCyc" id="MetaCyc:EG10571-MONOMER"/>
<dbReference type="EvolutionaryTrace" id="P0AE72"/>
<dbReference type="PRO" id="PR:P0AE72"/>
<dbReference type="Proteomes" id="UP000000318">
<property type="component" value="Chromosome"/>
</dbReference>
<dbReference type="Proteomes" id="UP000000625">
<property type="component" value="Chromosome"/>
</dbReference>
<dbReference type="GO" id="GO:0032991">
<property type="term" value="C:protein-containing complex"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="CAFA"/>
</dbReference>
<dbReference type="GO" id="GO:0003690">
<property type="term" value="F:double-stranded DNA binding"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="CAFA"/>
</dbReference>
<dbReference type="GO" id="GO:0042803">
<property type="term" value="F:protein homodimerization activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="CAFA"/>
</dbReference>
<dbReference type="GO" id="GO:0044877">
<property type="term" value="F:protein-containing complex binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="CAFA"/>
</dbReference>
<dbReference type="GO" id="GO:0097351">
<property type="term" value="F:toxin-antitoxin pair type II binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="CAFA"/>
</dbReference>
<dbReference type="GO" id="GO:0051291">
<property type="term" value="P:protein heterooligomerization"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="CAFA"/>
</dbReference>
<dbReference type="InterPro" id="IPR039052">
<property type="entry name" value="Antitox_PemI-like"/>
</dbReference>
<dbReference type="InterPro" id="IPR007159">
<property type="entry name" value="SpoVT-AbrB_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR037914">
<property type="entry name" value="SpoVT-AbrB_sf"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR40516">
<property type="entry name" value="PTHR40516"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF04014">
<property type="entry name" value="MazE_antitoxin"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00966">
<property type="entry name" value="SpoVT_AbrB"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF89447">
<property type="entry name" value="SSF89447"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS51740">
<property type="entry name" value="SPOVT_ABRB"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0181">Complete proteome</keyword>
<keyword id="KW-0238">DNA-binding</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0678">Repressor</keyword>
<keyword id="KW-1277">Toxin-antitoxin system</keyword>
<keyword id="KW-0804">Transcription</keyword>
<keyword id="KW-0805">Transcription regulation</keyword>
<feature type="chain" description="Antitoxin MazE" id="PRO_0000089649">
<location>
<begin position="1"/>
<end position="82"/>
</location>
</feature>
<feature type="domain" description="SpoVT-AbrB" evidence="3">
<location>
<begin position="4"/>
<end position="49"/>
</location>
</feature>
<feature type="mutagenesis site" description="Binds poorly to DNA." evidence="8">
<original>R</original>
<variation>A</variation>
<location>
<position position="8"/>
</location>
</feature>
<feature type="mutagenesis site" description="Does not bind to DNA." evidence="8">
<original>R</original>
<variation>A</variation>
<location>
<position position="16"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="6"/>
<end position="9"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="12"/>
<end position="15"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="19"/>
<end position="24"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="33"/>
<end position="38"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="41"/>
<end position="46"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="55"/>
<end position="60"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="64"/>
<end position="66"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1UB4"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2MRN"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU01076"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11071896"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12123459"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12533537"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12718874"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12743116"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12972253"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15316771"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15576778"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16390452"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19707553"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20005847"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21419338"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23432955"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="24375411"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="25564525"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8650219"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000305"/>
<sequence length="82" mass="9356" checksum="CD452A9AA4FB362E" modified="2005-12-06" version="1">
MIHSSVKRWGNSPAVRIPATLMQALNLNIDDEVKIDLVDGKLIIEPVRKEPVFTLAELVN
DITPENLHENIDWGEPKDKEVW
</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
</copyright>
</uniprot>